Latanoprost

CHEMBL1051 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
432.6 g/mol
LogP
4.3
Phase
4

A prostaglandin analog eye drop used to lower intraocular pressure in glaucoma and ocular hypertension. It works by increasing the outflow of aqueous humor from the eye, reducing pressure that can damage the optic nerve.

Peso Molecular

432,6000 g/mol

LogP

4,30

TPSA

87,00 Ų

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O

InChI

InChI=1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1

Molecular Formula

C26H40O5

HBD / HBA

3 / 5

Ligações Rotacionáveis

14

Átomos Pesados

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A prostaglandin analog eye drop used to lower intraocular pressure in glaucoma and ocular hypertension. It works by increasing the outflow of aqueous humor from the eye, reducing pressure that can damage the optic nerve.

Yes, Latanoprost is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1051. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5311221. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.